News & Press Releases
Filter by:
Mintz has added sought-after private equity dealmaker Griffin Doty as a Member in its New York office, further advancing the firm’s strategic growth and investment in its corporate practice in a highly competitive market. Griffin is a recognized presence in private equity circles, and known for his creative problem-solving on complex, high-stakes transactions. He joins from McDermott Will & Schulte.
Mintz advised the underwriters in connection with Avalo Therapeutics’ $431.3 million public offering of common stock and pre-funded warrants.
Mintz advised the underwriters in connection with InflaRx’s $150 million underwritten offering of ordinary shares.
Robert Vlasis shared insights in a Law360 article about the U.S. International Trade Commission’s proposed rule requiring disclosure of litigation funding in intellectual property cases.
Michelle Capezza was quoted in a Fiduciary News article examining why the 401(k) start-up tax credit is underutilized by small employers.
Mintz advised Axoft, a neurotechnology company, on a $55 million Series A financing round. The funding will be used to expand Axoft’s clinical trials globally and progress US regulatory approval for its implantable Brain-Computer Interfaces (iBCIs).
